429 related articles for article (PubMed ID: 12411415)
1. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.
Francischi JN; Chaves CT; Moura AC; Lima AS; Rocha OA; Ferreira-Alves DL; Bakhle YS
Br J Pharmacol; 2002 Nov; 137(6):837-44. PubMed ID: 12411415
[TBL] [Abstract][Full Text] [Related]
2. Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan.
França DS; Ferreira-Alves DL; Duarte ID; Ribeiro MC; Rezende RM; Bakhle YS; Francischi JN
Neuropharmacology; 2006 Jul; 51(1):37-43. PubMed ID: 16620880
[TBL] [Abstract][Full Text] [Related]
3. Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?
Gassani BC; Rezende RM; Paiva-Lima P; Ferreira-Alves DL; dos Reis WG; Bakhle YS; de Francischi JN
Pharmacol Res; 2010 Nov; 62(5):439-43. PubMed ID: 20600917
[TBL] [Abstract][Full Text] [Related]
4. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.
Pinheiro RM; Calixto JB
Inflamm Res; 2002 Dec; 51(12):603-10. PubMed ID: 12558194
[TBL] [Abstract][Full Text] [Related]
5. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids.
Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN
Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological analysis of cyclooxygenase-1 in inflammation.
Smith CJ; Zhang Y; Koboldt CM; Muhammad J; Zweifel BS; Shaffer A; Talley JJ; Masferrer JL; Seibert K; Isakson PC
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13313-8. PubMed ID: 9789085
[TBL] [Abstract][Full Text] [Related]
8. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
9. Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat.
El-Shenawy SM; Abdel-Salam OM; Baiuomy AR; El-Batran S; Arbid MS
Pharmacol Res; 2002 Sep; 46(3):235-43. PubMed ID: 12220966
[TBL] [Abstract][Full Text] [Related]
10. Peripheral mu-, kappa- and delta-opioid receptors mediate the hypoalgesic effect of celecoxib in a rat model of thermal hyperalgesia.
Correa JD; Paiva-Lima P; Rezende RM; Dos Reis WG; Ferreira-Alves DL; Bakhle YS; Francischi JN
Life Sci; 2010 Jun; 86(25-26):951-6. PubMed ID: 20451533
[TBL] [Abstract][Full Text] [Related]
11. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats.
Dirig DM; Isakson PC; Yaksh TL
J Pharmacol Exp Ther; 1998 Jun; 285(3):1031-8. PubMed ID: 9618405
[TBL] [Abstract][Full Text] [Related]
12. Studies on the anti-inflammatory effect of fluoxetine in the rat.
Abdel-Salam OM; Baiuomy AR; Arbid MS
Pharmacol Res; 2004 Feb; 49(2):119-31. PubMed ID: 14643692
[TBL] [Abstract][Full Text] [Related]
13. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
Wallace JL; Chapman K; McKnight W
Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
[TBL] [Abstract][Full Text] [Related]
14. ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
Harris RR; Black L; Surapaneni S; Kolasa T; Majest S; Namovic MT; Grayson G; Komater V; Wilcox D; King L; Marsh K; Jarvis MF; Nuss M; Nellans H; Pruesser L; Reinhart GA; Cox B; Jacobson P; Stewart A; Coghlan M; Carter G; Bell RL
J Pharmacol Exp Ther; 2004 Dec; 311(3):904-12. PubMed ID: 15277581
[TBL] [Abstract][Full Text] [Related]
15. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation.
Nantel F; Denis D; Gordon R; Northey A; Cirino M; Metters KM; Chan CC
Br J Pharmacol; 1999 Oct; 128(4):853-9. PubMed ID: 10556918
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes.
Mazario J; Gaitan G; Herrero JF
Neuropharmacology; 2001 Jun; 40(7):937-46. PubMed ID: 11378164
[TBL] [Abstract][Full Text] [Related]
17. Modulation of inflammatory paw oedema by cysteamine in the rat.
Salam OM
Pharmacol Res; 2002 Apr; 45(4):275-84. PubMed ID: 12030790
[TBL] [Abstract][Full Text] [Related]
18. Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice.
Siqueira-Junior JM; Peters RR; Brum-Fernandes AJ; Ribeiro-do-Valle RM
Pharmacol Res; 2003 Nov; 48(5):437-43. PubMed ID: 12967587
[TBL] [Abstract][Full Text] [Related]
19. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of selective COX-2 inhibitors.
Süleyman H; Demircan B; Karagöz Y; Oztaşan N; Süleyman B
Pol J Pharmacol; 2004; 56(6):775-80. PubMed ID: 15662090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
